Reply to Kalil et al, "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"
Recommended Citation
Sakoulas G, Geriak M, Haddad F, Rose W, LaPlante K, Zervos M, Kullar R, and Nizet V. Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?" Antimicrob Agents Chemother 2019; 63(11).
Document Type
Article
Publication Date
11-1-2019
Publication Title
Antimicrob agents chemother
PubMed ID
31640978
Volume
63
Issue
11
COinS
